首页> 美国卫生研究院文献>EBioMedicine >Oral administration of maternal vaginal microbes at birth to restore gut microbiome development in infants born by caesarean section: A pilot randomised placebo-controlled trial
【2h】

Oral administration of maternal vaginal microbes at birth to restore gut microbiome development in infants born by caesarean section: A pilot randomised placebo-controlled trial

机译:口服母体阴道微生物在出生时恢复患有剖腹产婴儿的肠道微生物组发育:试点随机安慰剂对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Birth by caesarean section (CS) is associated with aberrant gut microbiome development and greater disease susceptibility later in life. We investigated whether oral administration of maternal vaginal microbiota to infants born by CS could restore their gut microbiome development in a pilot single-blinded, randomised placebo-controlled trial (Australian New Zealand Clinical Trials Registry, ACTRN12618000339257).
机译:通过剖腹产(CS)出生与异常肠道微生物组发育有关,并在生命后面的疾病易感性有关。我们调查了母亲阴道微生物的口服给CS出生的婴儿是否可以在试验单一盲目的随机安慰剂对照试验(澳大利亚新西兰临床试验登记处,ACTRN12618000339257)中恢复他们的肠道微生物组发育。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号